Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Structure-Based Development of 3,5-Dihydroxybenzoyl-Hydrazineylidene As Tyrosinase Inhibitor; in Vitro And in Silico Study Publisher Pubmed



Bagheri A1 ; Moradi S1 ; Iraji A2, 3, 4 ; Mahdavi M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Chemistry, Islamic Azad University, North Tehran Branch, Tehran, Iran
  2. 2. Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Scientific Reports Published:2024


Abstract

A series of new analogs of 3,5-dihydroxybenzoyl-hydrazineylidene conjugated to different methoxyphenyl triazole (11a-n) synthesized using click reaction. The structures of all synthesized compounds were characterized by FTIR, 1H, 13C-NMR spectroscopy, and CHO analysis. The tyrosinase inhibitory potential of the synthesized compounds was studied. The newly synthesized scaffolds were found to illustrate the variable degree of the inhibitory profile, and the most potent analog of this series was that one bearing 4-methoxyphenyl moiety, and exhibited an IC50 value of 55.39 ± 4.93 µM. The kinetic study of the most potent derivative reveals a competitive mode of inhibition. Next, molecular docking studies were performed to understand the potent inhibitor's binding mode within the enzyme's binding site. Molecular dynamics simulations were accomplished to further investigate the orientation and binding interaction over time and the stability of the 11m-tyrosinase complex. © 2024, The Author(s).
Related Docs
View other Related Docs
1. Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors, Heliyon (2023)
2. Design, Synthesis, Biological Evaluation, and Molecular Docking Study of Thioxo-2,3-Dihydroquinazolinone Derivative As Tyrosinase Inhibitors, Journal of Molecular Structure (2022)
3. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides As Tyrosinase Inhibitors, Chemistry and Biodiversity (2022)
4. Thioquinoline Derivatives Conjugated to Thiosemicarbazide As Potent Tyrosinase Inhibitors With Anti-Melanogenesis Properties, Scientific Reports (2023)
5. Evaluating the Effects of Disubstituted 3-Hydroxy-1H-Pyrrol-2(5H)-One Analog As Novel Tyrosinase Inhibitors, Bioorganic Chemistry (2022)
6. Design, Synthesis, Spectroscopic Characterization, in Vitro Tyrosinase Inhibition, Antioxidant Evaluation, in Silico and Kinetic Studies of Substituted Indole-Carbohydrazides, Bioorganic Chemistry (2022)
7. Synthesis and Tyrosinase Inhibitory Activities of Novel Isopropylquinazolinones, BMC Chemistry (2023)
8. Evaluation of Novel 2-(Quinoline-2-Ylthio)Acetamide Derivatives Linked to Diphenyl-Imidazole As Α-Glucosidase Inhibitors: Insights From in Silico, in Vitro, and in Vivo Studies on Their Anti-Diabetic Properties, European Journal of Medicinal Chemistry (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Mahdavi (8)
Bagher Larijani (7)
Other Related Docs
9. Design, Synthesis, and Molecular Docking Studies of Diphenylquinoxaline-6-Carbohydrazide Hybrids As Potent Α-Glucosidase Inhibitors, BMC Chemistry (2022)